Bile Acid
[Bile Acid]
EPTIS Ringversuch Nr. 142639 | Letze Änderung 2024-12-17 | URL: https://www.eptis.bam.de/pts142639 https://www.eptis.bam.de/pts142639
| Name des Anbieters | |||||||||||||
| Name des Anbieters | Weqas Weqas | ||||||||||||
| Ansässig in | United Kingdom | ||||||||||||
| Sprache(n) | |||||||||||||
| Anmerkungen | Three liquid human serum samples covering an appropriate range for the diagnosis and monitoring of Cholestasis in Pregnancy. A linear series of up to 9 pools are prepared in serum containing a mixture of Cholic acid and Deoxycholic acid, the ratio of which reflects both physiological levels and pathological levels observed in ICP. Target values for both Cholic acid and Chenodeoxycholic acid are assayed using a ID – GC Mass Spectrometer for each sample. The programme is designed to assess laboratory and method performance, including bias, within and between batch imprecision, linearity, trueness, sensitivity and specificity of TSBA. Key Features: Linear panels assigned by a higher meteorological order reference method. Panel of liquid human serum samples covering an appropriate range and BA ratio for the diagnosis and monitoring of ICP Challenging samples containing UDCA and other BA to determine specificity. Analytical performance Specification based on Milan Model 3. For more information: https://www.weqas.com/services/eqa/bileacid/ or contact@weqas.com | ||||||||||||
| Klassifizierung | |||||||||||||
| Produktgruppen |
Health care / medical devices
|
||||||||||||
| Prüfgebiete |
Medical analysis
|
||||||||||||
| Technische Einzelheiten | |||||||||||||
|
|||||||||||||
| Ringversuchsziele | |||||||||||||
| Zielgruppe des Ringversuchs | Laboratory Diagnostic Services | ||||||||||||
| Relevante Rechtsvorschriften oder Normen | Accreditation by UKAS on the basis of ISO/IEC 17043. | ||||||||||||
| Weitere Ziele | validation of testing methods | ||||||||||||
| Teilnehmerzahl | |||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/ IEC 17043 |
||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||||||||
| Kosten | |||||||||||||
| Teilnahmegebühr | Fee dependent on number of participating sections and proximetry of testing methods. | ||||||||||||
| Regelmässig durchgeführt | Ja (Frequency: Monthly. Samples: 3 x 0.5 mL) | ||||||||||||
| Der Ringversuch wird durchgeführt seit | 2004 | ||||||||||||
| Kontaktdaten des Anbieters | |||||||||||||
| Anbieter | Kontaktperson | ||||||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Telefon: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 32884 Fax: E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.